Review Articles

Acute and Subclinical Myocardial Injury in COVID-19



Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients—with or without established cardiovascular disease—incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.


COVID-19coronaviruscardiovascular diseasemyocardial injurymyocarditis
  • Year: 2021
  • Volume: 17 Issue: 5
  • Page/Article: 22-30
  • DOI: 10.14797/mdcvj.1038
  • Submitted on 14 Sep 2021
  • Accepted on 11 Oct 2021
  • Published on 15 Dec 2021
  • Peer Reviewed